COVID-19 associated acute transverse myelitis unresponsive to steroid therapy

Mohammad Sameer Shafi; Shahaan Shafi; Reza Ghasemi; Motahareh Vameghstahbanati

doi:10.18203/2320-6012.ijrms20220990

Authors

Mohammad Sameer Shafi Kidney Care Center, Chicago, IL, United States
Shahaan Shafi Kidney Care Center, Chicago, IL, United States
Reza Ghasemi Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Motahareh Vameghstahbanati McGill University Faculty of Medicine, 12367, Experimental Medicine, Montreal, Quebec, Canada

DOI:

https://doi.org/10.18203/2320-6012.ijrms20220990

Keywords:

COVID19, Transverse myelitis, Corticosteroids

Abstract

A 63-year-old female presented to hospital with nausea, vomiting and abdominal pain. After primary evaluation, SARS-CoV-2 infection was suspected and confirmed via polymerase chain reaction (PCR) assay. She was started on broad spectrum antibiotics and remdesivir. After 12 days of hospitalization, she reported bilateral weakness and numbness of lower extremities and increased shortness of breath in the absence of fever. MRI with contrast was performed which showed intrinsic spinal cord lesion at the C7-T3 levels suggestive of transverse myelitis. She was started on IV steroids and was transferred to tertiary hospital for higher level of care. On neurological exam, there was an obvious reduction in the power of lower extremities and hyperreflexia was noted. Due to increasing weakness, MRI of cervical and thoracic spine was repeated and subsequently was started on Solu-Medrol 1-gram IV daily for 5 days. She was unresponsive to steroid therapy and refused plasmapheresis. Her course of hospitalization was complicated with acute on chronic renal failure and obstructive uropathy.

Metrics

Metrics Loading ...

References

Abolghasemi S, Sali S, Yadegarynia D. Impact of COVID-19 on 75 Immunocompromised Patients: Does Immunosuppression Alter the Clinical Course? Infect Epidemiol Microbiol. 2021;7(2):129-40.

Chow CCN, Magnussen J, Ip J, Su Y. Acute transverse myelitis in COVID-19 infection. BMJ Case Rep. 2020;13(8):e236720.

Azer SA. COVID-19: pathophysiology, diagnosis, complications and investigational therapeutics. New Microbes New Infect. Sep 2020;37:100738.

Chakraborty U, Chandra A, Ray AK, Biswas P. COVID-19-associated acute transverse myelitis: a rare entity. BMJ Case Rep. Aug 25 2020;13(8).

Whittaker A, Anson M, Harky A. Neurological Manifestations of COVID-19: A systematic review and current update. Acta Neurol Scand. Jul 2020;142(1):14-22.

West TW. Transverse myelitis--a review of the presentation, diagnosis, and initial management. Discov Med. Oct 2013;16(88):167-77.

Ahmad SA, Salih KH, Ahmed SF. Post COVID-19 transverse myelitis; a case report with review of literature. Ann Med Surg (Lond). Sep 2021;69:102749.

Krishnan C, Kaplin AI, Deshpande DM, Pardo CA, Kerr DA. Transverse Myelitis: pathogenesis, diagnosis and treatment. Front Biosci. 2004;9:1483-99.

Valiuddin H, Skwirsk B, Paz-Arabo P. Acute transverse myelitis associated with SARS-CoV-2: A Case-Report. Brain Behav Immun Health. 2020;5:100091.

Frohman EM, Wingerchuk DM. Clinical practice. Transverse myelitis. N Engl J Med. 2010;363(6):564-72.

AlKetbi R, AlNuaimi D, AlMulla M. Acute myelitis as a neurological complication of Covid-19: A case report and MRI findings. Radiol Case Rep. Sep 2020;15(9):1591-5.

Baghbanian SM, Namazi F. Post COVID-19 longitudinally extensive transverse myelitis (LETM)-a case report. Acta Neurol Belg. Sep 18 2020:1-2.

Chow CCN, Magnussen J, Ip J, Su Y. Acute transverse myelitis in COVID-19 infection. BMJ Case Rep. 2020;13(8).

Maideniuc C, Memon AB. Acute necrotizing myelitis and acute motor axonal neuropathy in a COVID-19 patient. J Neurol. 2021;268(2):739.

Zoghi A, Ramezani M, Roozbeh M, Darazam IA, Sahraian MA. A case of possible atypical demyelinating event of the central nervous system following COVID-19. Mult Scler Relat Disord. 2020;44:102324.

Conde Cardona G, Quintana Pájaro LD, Quintero Marzola ID, Ramos Villegas Y, Moscote Salazar LR. Neurotropism of SARS-CoV 2: Mechanisms and manifestations. J Neurol Sci. 2020;412:116824.

Fumery T, Baudar C, Ossemann M, London F. Longitudinally extensive transverse myelitis following acute COVID-19 infection. Mult Scler Relat Disord. 2021;48:102723.

Wu Y, Xu X, Chen Z. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18-22.

Desforges M, Le Coupanec A, Dubeau P. Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Viruses. 2019;12(1).

Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the Nervous System. Cell. Oct 1 2020;183(1):16-27.

Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033-4.

Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846-8.

Zhu Z, Cai T, Fan L. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019. Int J Infect Dis. 2020;95:332-9.

Moreno-Escobar MC, Kataria S, Khan E. Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature. J Neuroimmunol. 2021;353:577523.

Shahali H, Ghasemi A, Farahani RH, Nezami Asl A, Hazrati E. Acute transverse myelitis after SARS-CoV-2 infection: a rare complicated case of rapid onset paraplegia. J Neurovirol. 2021;27(2):354-8.

Munz M, Wessendorf S, Koretsis G. Acute transverse myelitis after COVID-19 pneumonia. J Neurol. 2020;267(8):2196-7.

Nemţan V, Manole E, Hacina E. Acute transverse myelitis in a HIV-positive patient with COVID-19. Moldovan Med J. 2020;63(5):51-53.

Kincaid O, Lipton HL. Viral myelitis: an update. Curr Neurol Neurosci Rep. 2006;6(6):469-74.